Stay updated with breaking news from Peter Gasser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mind Medicine(NASDAQ:NASDAQ:MNMD) Q1 2022 Earnings Conference Call May16, 2022, 08:30AM ET Company Participants Rob Barrow - CEO Dan Karlin - Chief Medical Officer Miri Halperin Wernli -...
/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...
Millions of people in Germany have been diagnosed with depression. Researchers believe that drugs such as LSD and psilocybin can offer an effective treatment. They could also bring big profits.
COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy COMPASS Pathways announces publication in of paper on therapist training programme for psilocybin therapy Formal and scalable methodology for psychological support in psilocybin therapy London, UK 3 February 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has shared details of its comprehensive and rigorous therapist … COMPASS Pathways announces publication in Fronti...
Compass Pathways: COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy Frontiers in Psychiatry Formal and scalable methodology for psychological support in psilocybin therapy London, UK - 3 February 2021 COMPASS Pathways plc today. The programme sets out a formal and scalable methodology for psychological support in psilocybin therapy. It is currently being used to train therapists taking part in COMPASS's phase IIb clinical trial of COMP360 psilocybin therapy for treatment-resistant depression, as approved by the U...